arznei-telegramm Logo a-t Kurzlogo
    ❮ a-t 6/2018 a-t ❯
    This is a translation of the table of contents. One article of each issue is translated and freely available.
    table of contents
    NEW ON THE MARKET

    Inactivated zoster vaccine SHINGRIX

    Me too: SGLT2 inhibitor ertugliflozin (in STEGLUJAN)

    a-t READERS QUESTIONS AND COMMENTS

    Statins: “treat-to-target” or “fire-and-forget” strategies – What is new?

    Parecoxib (DYNASTAT) against postoperative pain?

    IN BRIEF

    Confirmed: no analgesics alone for uncomplicated cystitis

    CURRENT ADR NETWORK REPORT

    Hearing loss with secukinumab (COSENTYX)?
    free

    SIDE EFFECTS

    Hypersensitivity reactions to flurbiprofen throat drugs

    Dietary supplement kratom: FDA warns against fatal risks

    Increased risk of secondary cancer with denosumab (XGEVA)

    Neural tube defects with dolutegravir (TIVICAY, in TRIUMEQ)

    arznei-telegramm

    Independent drug information – in English

    Concise, critical evaluations of drugs and medical devices for evidence-based therapy and patient advice on benefits and risks – independent, ad-free and funded exclusively by subscriptions.

    Browse free articles